Drulak 1988.
Study characteristics | |||
Patient sampling | Cross‐sectional study
Prospective design
Sample: unclear
Direct comparison of different RADTs: no
Direct comparison of several throat culture techniques: no
Person performing the throat sample: other ("staff") Exclusion if recent antibiotics use before inclusion: no Clinical selection of patients: none Presenting signs and symptoms: pharyngitis Age range for inclusion: < 18 years |
||
Patient characteristics and setting | Sample size: 280
Age (distribution): not reported GAS prevalence according to culture (with 95% confidence interval): 20.4% (95% CI not reported) Country of study: Canada Sex (% of girls): not reported Clinical severity assessment: none Clinical setting: outpatient clinic ("outpatient department of a large paediatric institution") Single‐centre study |
||
Index tests | Throat swab: 1 double swab (1 swab for the RADT, 1 swab for culture) Commercial name of the RADT: Visuwell Strep A (ADI) Type of RADT: EIA |
||
Target condition and reference standard(s) | Throat culture medium: standard Atmosphere of incubation: anaerobic during 24 hours then aerobic with CO2 enrichment during 24 hours Duration of incubation: 48 hours GAS confirmation: other (capillary tube precipitation) Number of plates inoculated: 1 Assessment of GAS antibody response: no Relevant details: ‐ | ||
Flow and timing | No follow‐up | ||
Comparative | |||
Type of study | Journal article | ||
Notes | The study had 2 parts: 1 with adults and children (n = 585), the second with children only (n = 280). The data used for this systematic review were restricted to the second part because paediatric data were not extractable from the first part of the study Study conducted by the manufacturer of the RADT under investigation (Visuwell, ADI) |
||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was it a cross‐sectional study or a RCT? | Yes | ||
Were selection criteria clearly described (at least presenting signs and symptoms and age limits for inclusion)? | Yes | ||
Was clinical selection of patients avoided? | Yes | ||
Were patients seen in an ambulatory care setting? | Yes | ||
Low | Low | ||
DOMAIN 2: Index Test All tests | |||
Were the RADT results interpreted with blinding of the results of culture? | Yes | ||
Was the type of the RADT mentioned (EIA or OIA)? | Yes | ||
Were RADTs conducted during consultation time? | No | ||
Low | High | ||
DOMAIN 3: Reference Standard | |||
Were culture results interpreted with blinding of the results of the RADT? | Unclear | ||
Is the throat culture method likely to correctly identify GAS (laboratory culture on a blood agar plate during 48 hr)? | Yes | ||
Were the culture medium, atmosphere, duration of incubation and GAS‐confirmation technique described? | Yes | ||
Unclear | Low | ||
DOMAIN 4: Flow and Timing | |||
Was the delay between the performance of the RADT and throat culture plating less than 48 hours? | Unclear | ||
Did all patients receive a throat culture? | Yes | ||
Did patients receive the same throat culture method? | Yes | ||
Were undetermined/uninterpretable results reported? | No | ||
Were withdrawals from the study explained? | Yes | ||
Low |